Involvement of GATOR complex genes in familial focal epilepsies and focal cortical dysplasia

• DOI: 10.1111/epi.13391
• Publication Date: 2016-05-13T06:56:57Z
• Authors: Sarah Weckhuysen; Elise Marsan; Virginie Lambrecq; Cécile Marchal; Mélanie Morin‐Bru...; Isabelle An‐Gourf...; Michel Baulac; Martine Fohlen; Christine Kallay ...; Margitta Seeck; Pierre de la Grange; Bart Dermaut; Alfred Meurs; Pierre Thomas; Francine Chassoux; Eric Leguern; Fabienne Picard; Stéphanie Baulac
• Keywords: Adult; Male; DEPDC5; DNA Mutational Analysis; NPRL3; Cohort Studies; 03 medical and health sciences; familial focal epilepsies; 0302 clinical medicine; NPRL2; Humans; genetics; Genetic Predisposition to Disease; [SDV.NEU] Life Sciences [q-bio]/Neurons and Cognition [q-bio.NC]; Child; 35 references; Aged; Aged, 80 and over; Family Health; GTPase-Activating Proteins; Infant, Newborn; fical cortical dysplasia; Infant; info:eu-repo/classification/ddc/616.8; 3249 words (including summary); Middle Aged; complex genes; Magnetic Resonance Imaging; ddc:616.8; Malformations of Cortical Development; mTOR pathway; SUDEP 22 text pages; 5 figures; Child, Preschool; Involvement of Gator; Mutation; 1 table; [SDV.NEU]Life Sciences [q-bio]/Neurons and Cognition [q-bio.NC]; Female; Epilepsies, Partial

SummaryObjectiveThe discovery of mutations in DEPDC5 in familial focal epilepsies has introduced a novel pathomechanism to a field so far dominated by ion channelopathies. DEPDC5 is part of a complex named GAP activity toward RAGs (GATOR) complex 1 (GATOR1), together with the proteins NPRL2 and NPRL3, and acts to inhibit the mechanistic target of rapamycin (mTOR) complex 1 (mTORC1) pathway. GATOR1 is in turn inhibited by the GATOR2 complex. The mTORC1 pathway is a major signaling cascade regulating cell growth, proliferation, and migration. We aimed to study the contribution of GATOR complex genes to the etiology of focal epilepsies and to describe the associated phenotypical spectrum.MethodsWe performed targeted sequencing of the genes encoding the components of the GATOR1 (DEPDC5, NPRL2, and NPRL3) and GATOR2 (MIOS, SEC13, SEH1L, WDR24, and WDR59) complex in 93 European probands with focal epilepsy with or without focal cortical dysplasia. Phospho‐S6 immunoreactivity was used as evidence of mTORC1 pathway activation in resected brain tissue of patients carrying pathogenic variants.ResultsWe identified four pathogenic variants in DEPDC5, two in NPRL2, and one in NPRL3. We showed hyperactivation of the mTORC1 pathway in brain tissue from patients with NPRL2 and NPRL3 mutations. Collectively, inactivating mutations in GATOR1 complex genes explained 11% of cases of focal epilepsy, whereas no pathogenic mutations were found in GATOR2 complex genes. GATOR1‐related focal epilepsies differ clinically from focal epilepsies due to mutations in ion channel genes by their association with focal cortical dysplasia and seizures emerging from variable foci, and might confer an increased risk of sudden unexplained death in epilepsy (SUDEP).SignificanceGATOR1 complex gene mutations leading to mTORC1 pathway upregulation is an important cause of focal epilepsy with cortical malformations and represents a potential target for novel therapeutic approaches.